To evaluate whether serum microRNAs can predict survival in nasopharyngeal carcinoma (NPC) patients, we analyzed the serum microRNA expression profiles in 8 NPC patients with shorter-survival time and
PARP inhibitors can be used to treat solid tumors that often have mutations in important homologous recombination (HR) genes, such as BRCA1/2. While other kinds of tumors could also experience HR defi
Tissue specific and enriched miRNAs identified by Lilly. Tissue specific and tissue enriched miRNAs identified by Eli Lilly are listed under the organ in which they are most abundantly expressed. Tiss
